Pruritus
Pruritus
Explore linked clinical trials. Standard reference: MESH:M001793574 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| J-LINX: Japan LINerixibat eXtension Study | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, skin disorder | Not yet recruiting | Phase 3 | 2026-10-06 | NCT07860710 | |
| Evaluation of Maralixibat in Pruritus Associated With General Cholestatic Liver Disease (EXPAND) | Cholangitis, Sclerosing, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Abnormalities, Digestive System Diseases, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, bile duct disorder, biliary atresia, biliary tract disorder, cholangitis, skin disorder | Active, not recruiting | Phase 3 | 2026-10-06 | NCT06553768 | |
| Novel Strategies for Reducing Burn Scar Itch | Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, burn, injury, skin disorder | Recruiting | Phase 3 | 2026-10-05 | NCT06801626 | |
| Serum Substance P, Neuropathic Pain, and Central Sensitization Across Treatment Groups in Chronic Plaque Psoriasis | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder, skin disorder | Recruiting | Not stated | 2026-09-28 | NCT07844772 | |
| Efficacy and Safety of ATTO-1310 in the Treatment of Participants With Chronic Pruritus of Unknown Origin | Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, skin disorder | Not yet recruiting | Phase 2 | 2026-09-22 | NCT07833306 | |
| Topical Minocycline for CARP | Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, cyclopia sequence, papillomatosis, confluent and reticulated, skin disorder | Not yet recruiting | Early phase 1 | 2026-09-21 | NCT07462702 | |
| Cervical Traction to Reduce Gabaergic Medication Use for Neuropathic Itch | Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, skin disorder | Recruiting | Not applicable | 2026-09-09 | NCT06751056 | |
| Itchy Scalp Biomarkers Exploration | Dandruff, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, dermatitis, scalp dermatosis, skin disorder | Active, not recruiting | Not stated | 2026-09-04 | NCT07805031 | |
| Efficacy and Safety Study to Evaluate SD-101 in Epidermolysis Bullosa | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Abnormalities, Skin Manifestations, Skin and Connective Tissue Diseases, epidermolysis bullosa, hereditary disease, hereditary skin disorder, skin disorder, vesiculobullous skin disease | Recruiting | Phase 3 | 2026-09-04 | NCT07482787 | |
| Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients | Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, dermatitis, prurigo, skin disorder | Not yet recruiting | Phase 2 | 2026-09-03 | NCT07620561 | |
| A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis | Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Diseases, Papulosquamous, Skin Manifestations, Skin and Connective Tissue Diseases, exanthem, psoriasis, skin disorder | Recruiting | Phase 3 | 2026-09-03 | NCT06979453 | |
| Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus | Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Urogenital Diseases, chronic renal failure syndrome, kidney disorder, kidney failure, skin disorder, urinary system disorder | Recruiting | Phase 2 | 2026-09-01 | NCT06593392 | |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) | Cholangitis, Sclerosing, Digestive System Diseases, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, primary sclerosing cholangitis, skin disorder | Active, not recruiting | Phase 2 | 2026-08-26 | NCT04663308 | |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, skin disorder | Active, not recruiting | Phase 2 | 2026-08-25 | NCT05050136 | |
| Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream. | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Diseases, Eczematous, Skin Manifestations, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 4 | 2026-08-13 | NCT07560618 | |
| Cardamom and Topical Roseomonas in Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Diseases, Eczematous, Skin Manifestations, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, exanthem, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 2 | 2026-08-13 | NCT06096857 | |
| A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes | Bacterial Infections and Mycoses, Foot Dermatoses, Foot Diseases, Infections, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, dermatomycosis, fungal infectious disease, skin disorder, skin disorder caused by infection, tinea infection, tinea pedis | Recruiting | Phase 1 | 2026-08-04 | NCT07668999 | |
| Drug-induced Liver Injury: Itching Study | Chemically-Induced Disorders, Digestive System Diseases, Drug-Induced Liver Disease, Drug-Related Side Effects and Adverse Reactions, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, drug-induced liver injury, liver disorder, poisoning, skin disorder | Recruiting | Not stated | 2026-07-27 | NCT06446609 | |
| High-power Laser Therapy for Notalgia Paresthetica. | Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, skin disorder | Recruiting | Not applicable | 2026-07-20 | NCT07356362 | |
| Topical Chinese Medicine and Exosome Mechanisms for Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Diseases, Eczematous, Skin Manifestations, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Active, not recruiting | Phase 2 | 2026-07-09 | NCT07693400 | |
| Effects of Non-Invasive Vagus Nerve Stimulation in Adolescent Burn Patients | Dyssomnias, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Sleep Disorders, Intrinsic, anxiety disorder, burn, injury, insomnia, nervous system disorder, psychiatric disorder, skin disorder, sleep-wake disorder | Enrolling by invitation | Not applicable | 2026-07-07 | NCT07566923 | |
| Effect of Non-Invasive Vagus Nerve Stimulation in Burn Patients | Dyssomnias, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, Sleep Disorders, Intrinsic, anxiety disorder, burn, injury, insomnia, nervous system disorder, psychiatric disorder, skin disorder, sleep-wake disorder | Enrolling by invitation | Not applicable | 2026-07-07 | NCT07566871 | |
| Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC) | Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, skin disorder | Recruiting | Phase 3 | 2026-07-06 | NCT05263206 | |
| The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe Itching | Cholangitis, Sclerosing, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Fibrosis, Hypersensitivity, Immediate, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Diseases, Eczematous, Skin Manifestations, Skin and Connective Tissue Diseases, atopic eczema, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, cirrhosis of liver, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, intrahepatic cholestasis, liver disorder, primary biliary cholangitis, skin disorder | Not yet recruiting | Phase 2 | 2026-07-01 | NCT07678645 | |
| TriCalm Hydrogel® in the Treatment of Immunotherapy-Related Pruritus | Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, skin disorder | Recruiting | Phase 2 | 2026-06-30 | NCT06748404 |